ArticlePsychophysiology2025
Blunted P300 Prospectively Bridges Cognitive Reappraisal and Depressive Symptoms.
Article in Psychophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blunted P300 Prospectively Bridges Cognitive Reappraisal and Depressive Symptoms.Psychophysiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cognitive reappraisal is a crucial modulator of depression. Scant research has examined how the usage of cognitive reappraisal is prospectively linked with depressive symptoms through its modulation effect on P300. Moreover, there is limited knowledge about how the social-environmental context, such as stressful societal disruption, could moderate this prospective process. Adopting a 6-month longitudinal design that recorded both behavioral and electroencephalogram data among 55 young adults (61.8% female) during the COVID-19 pandemic, this study examined the prospective associations from participants' Wave 1 [W1] usage of cognitive reappraisal strategy to W3 depressive symptoms through W2 P300 amplitude during an oddball task, and investigated the potential moderation effect of COVID-19 stress on this mediation path. Cognitive reappraisal was prospectively and indirectly linked to depressive symptoms through reduced P300 amplitude, which was suppressed by COVID-19 stress. Participants with more frequent use of cognitive reappraisal showed blunted P300 amplitude only when COVID-19 stress was low, which was subsequently linked to elevated depressive symptoms. Current findings highlight the central role of reduced P300 as a mediator between cognitive reappraisal and exacerbation of vulnerability for depressive symptoms. Moreover, current findings emphasize the interactive influence between the social-environmental context and cognitive strategy on psychiatric symptoms on a long-term timescale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.